Lobbying client

MEDA PHARMACEUTICALS

Pharmaceutical company specializing in respiratory and allergy products

Filings
8
Filed by
1
Reported in-house
—
Reported by firms
$240,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2010 to 2011

Filings

3 filings for 2011, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2011
WINNING STRATEGIES WASHINGTON $20,000 reported
1st Quarter - Report
1st Quarter 2011
WINNING STRATEGIES WASHINGTON $40,000 reported
Registration - Amendment
1st Quarter 2011
WINNING STRATEGIES WASHINGTON — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
WINNING STRATEGIES WASHINGTON 6 $240,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 8
Health Issues HCR 8

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.